ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The \"test and treat\" strategy for treating dyspeptic patients who are H. pylori positive is rapidly becoming the standard of care. This study will test the effectiveness of RHB-105, a new triple therapy to treat H. pylori infection in dyspeptic patients against an active comparator.
Epistemonikos ID: 4eb055806c08c180a7c16314fa017a1218c342f0
First added on: May 20, 2024